Choosing appropriate pharmacotherapy for drug-resistant HIV.

Author: CapettiAmedeo, RizzardiniGiuliano

Paper Details 
Original Abstract of the Article :
Despite the potency of current antiretrovirals, some patients continue to struggle with the management of the treatment of HIV due to drug resistance-associated mutations. The underlying causes of these developments are usually drug adherence and drug availability as well as the economic affordabili...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1080/14656566.2019.1570131

データ提供:米国国立医学図書館(NLM)

Navigating Drug-Resistant HIV: Choosing Appropriate Pharmacotherapy

The development of drug resistance poses a significant challenge in the management of HIV infection. This review explores the factors contributing to drug resistance and the strategies for choosing appropriate pharmacotherapy in these challenging cases.

Addressing Drug Resistance: A Multifaceted Approach

Researchers emphasize the importance of addressing drug resistance, highlighting the role of patient adherence, drug availability, and economic affordability in influencing treatment outcomes. They highlight the need for a strategic vision when choosing new regimens, considering factors such as genetic barrier, convenience, potency, drug-drug interactions, and tolerability.

A Desert of Drug Resistance: Finding New Paths

Think of drug resistance as a vast desert, where HIV can thrive and evade conventional treatments. Finding new paths through this desert requires a multifaceted approach, including preventive interventions, the development of new compounds, and strategies to minimize the emergence and transmission of drug-resistant mutations.

Dr. Camel's Conclusion

This review underscores the complexities of drug resistance in HIV treatment, highlighting the need for continued research and innovation to develop effective strategies for managing this challenging aspect of HIV care. The authors emphasize the importance of preventive interventions, patient education, and access to appropriate medications to optimize treatment outcomes.

Date :
  1. Date Completed 2019-04-08
  2. Date Revised 2019-04-08
Further Info :

Pubmed ID

30676115

DOI: Digital Object Identifier

10.1080/14656566.2019.1570131

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.